Remove Access Remove Decriminalization Remove Policy Remove Therapy
article thumbnail

WI’s Legalization Push, MI’s Psychedelic Bill, & Enthea’s Growing Network

Veriheal

If approved, the bill would decriminalize psychedelics for personal use and noncommercial activities like cultivation, provided there is no monetary exchange involved. Along with their medical properties, psychedelics’ low potential for abuse and psychological harm means legalization is just “good public policy” Sen. Irwin says.

Therapy 98
article thumbnail

Harvard Is Launching America’s First Psychedelics Law and Policy Center

SpeedWeed

Harvard Law School is planning to open the first US policy center focused on the legalization and regulation of psychedelics like psilocybin, MDMA, and LSD. . By analyzing social, legal, and political barriers to access in this context, we hope to advance the understanding of their potential impact as therapeutics.”.

Policy 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Seattle City Council Affirms Support for Decriminalization of Entheogens

Cannabis Law Report

In his remarks, Lewis underscored his appreciation for his colleagues’ support for decriminalization. “It It is a long overdue conversation to decriminalize these non-addictive natural substances. City To Decriminalize Psychedelics. We need to join the national conversation.”. Seattle Becomes Largest U.S.

article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

Alternative medicine is becoming more widely acknowledged and practiced than ever before, opening the door for therapies like psychedelics to enter the world of mainstream healthcare. Psilocybin therapy is both studied and used by highly legitimate medical establishments. Ned Lamont signed a bill (HB 5506) to fund psychedelic therapy.

article thumbnail

Harvard Law School Announces the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

Cannabis Law Report

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. While psychedelic therapies make their way through the drug development pipeline, seven U.S.

Law 59
article thumbnail

Maine’s Health and Human Services Committee Votes Down Psilocybin-Assisted Therapy Proposal

Cannabis Law Report

This is a breakthrough therapy and it shows promise, but the science is not there yet.”. A Maine therapist with two patients benefiting from psychedelic drug-assisted therapy to treat PTSD and depression also expressed disappointment. cities also have moved to decriminalize psilocybin. BILL BASED ON OREGON’S. They were Sen.

Therapy 52
article thumbnail

Researchers Concerned About Whitewashing of Psychedelic-Assisted Mental Health Research

Cannabis Law Report

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Madison Natarajan, MS. – August 5, 2021.